New anticoagulants for the prevention of venous thromboembolism

New anticoagulants for the prevention of venous thromboembolism

Cecilia Becattini, Alessandra Lignani, Giancarlo AgnelliInternal and Cardiovascular Medicine and Stroke Unit, University of Perugia, ItalyAbstract: Anticoagulant drugs have an essential role in the prevention and treatment of thromboembolic diseases. Currently available anticoagulants substantially...

Full description

Bibliographic Details
Main Authors:	Cecilia Becattini, Alessandra Lignani, Giancarlo Agnelli
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-04-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/new-anticoagulants-for-the-prevention-of-venous-thromboembolism-a4205

Similar Items

New anticoagulants for the prevention and treatment of venous thromboembolism
by: Simon J McRae, et al.
Published: (2005-04-01)

The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants
by: Andrew D Blann, et al.
Published: (2009-09-01)

New anticoagulants for the treatment of venous thromboembolism
by: Caio Julio Cesar dos Santos Fernandes, et al.
Published: (2016-04-01)

Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
by: Adiguzel Cafer, et al.
Published: (2011-03-01)

The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01)

Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)

Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients
by: G&oacute;mez-Outes A, et al.
Published: (2013-05-01)

Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01)

Choice and Duration of Anticoagulation for Venous Thromboembolism
by: Aroosa Malik, et al.
Published: (2024-01-01)

Newer oral anticoagulants in venous thromboembolism
by: Sunil Modi, et al.
Published: (2021-01-01)

Anticoagulant therapy for acute venous thromboembolism
by: Hilal Ermiş, et al.
Published: (2017-09-01)

Direct oral anticoagulants and venous thromboembolism
by: Massimo Franchini, et al.
Published: (2016-09-01)

Novel Oral Anticoagulants for Stroke Prophylaxis and Venous Thromboembolism Prevention and Treatment
by: Laith G. Alsayegh
Published: (2015-08-01)

VENOUS THROMBOEMBOLISM IN CANCER: AN UPDATE OF TREATMENT AND PREVENTION IN THE ERA OF NEWER ANTICOAGULANTS
by: Waqas Qureshi, et al.
Published: (2016-07-01)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
by: Song AB, et al.
Published: (2019-06-01)

Oral anticoagulants: Optimizing venous thromboembolism management
by: Fahad A S. Aleidan
Published: (2019-01-01)

Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis
by: Karlyn A. Martin, et al.
Published: (2020-10-01)

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism
by: Wumaier K, et al.
Published: (2022-08-01)

Optimal duration of anticoagulant therapy in patients with venous thromboembolism
by: Gualtiero Palareti
Published: (2018-09-01)

Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes
by: Nichole E. Brunton, et al.
Published: (2021-05-01)

Direct oral anticoagulants for unusual‐site venous thromboembolism
by: Nicoletta Riva, et al.
Published: (2021-02-01)

Risk factors for Venous thromboembolism and duration of anticoagulation therapy
by: Antonijević Nebojša M., et al.
Published: (2013-01-01)

Direct oral anticoagulants and travel-related venous thromboembolism
by: Chamnanchanunt Supat, et al.
Published: (2018-11-01)

Direct oral anticoagulants in cancer-associated venous thromboembolism
by: Kirill Lobastov, et al.
Published: (2020-01-01)

ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLIC COMPLICATIONS: PROBLEMS AND PERSPECTIVES
by: N. M. Vorobieva, et al.
Published: (2015-03-01)

CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
by: I. S. Yavelov
Published: (2015-12-01)

Choosing an anticoagulant for a patient with venous thromboembolic complications
by: Yu. M. Stoyko, et al.
Published: (2016-06-01)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
by: Richard F. MacLehose, et al.
Published: (2021-05-01)

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
by: Vicky Mai, et al.
Published: (2019-01-01)

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
by: Yong-Jian Zhu, et al.
Published: (2021-05-01)

Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different?
by: Łukasz Wołowiec, et al.
Published: (2017-08-01)

Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different?
by: Łukasz Wołowiec, et al.
Published: (2017-08-01)

Expanding the possibilities of treatment and prevention of venous thromboembolic complications in cancer patients. The role of oral anticoagulants
by: R. A. Bredikhin, et al.
Published: (2022-10-01)

Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer
by: Benjamin Planquette, et al.
Published: (2019-06-01)

Postpartum prophylaxis of venous thromboembolism with anticoagulation: A case report
by: Yahya A. Mohzari, Pharm.D, et al.
Published: (2021-04-01)

Underutilization of Anticoagulant for Venous Thromboembolism Prophylaxis in Three Hospitals in Jakarta
by: T. Djumhana Atmakusuma, et al.
Published: (2016-05-01)

ORAL ANTICOAGULANTS IN THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS: FOCUS ON APIXABAN
by: M. Yu. Gilyarov, et al.
Published: (2017-12-01)

Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism
by: Liew, Ngoh Chin, et al.
Published: (2017)

Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis
by: V. I. Petrov, et al.
Published: (2016-03-01)